[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350897-105":59,"doc-detail-350897-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","exosomes-in-early-lung-cancer-diagnostics-the-current-state-of-progress-made-and-prospects","Exosomes in early lung cancer diagnostics: the current state of progress made and prospects","","Lung cancer mortality largely stems from late-stage diagnosis, when metastasis is common and treatment options are limited, resulting in low overall 5-year survival rates. Conventional screening such as low-dose computed tomography (LDCT) suffers from high false positives, overdiagnosis, unnecessary surgeries, and cumulative radiation risk. Tumor tissue sampling, though the diagnostic gold standard, is invasive and constrained by heterogeneity and variable tissue quality. Exosomal RNAs and proteins in body fluids are reviewed as stable, accessible, and specific candidates for noninvasive early detection, alongside established and emerging detection platforms.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exosomes-in-early-lung-cancer-diagnostics-the-current-state-of-progress-made-and-prospects/350897/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exosomes-in-early-lung-cancer-diagnostics-the-current-state-of-progress-made-and-prospects/350897.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",16,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is early lung cancer detection critical?","Question",{"text":113,"@type":114},"Late-stage diagnosis is common, often after metastasis has occurred, and therapeutic options are limited, leading to low survival rates. Early detection can reduce mortality by catching disease earlier.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What are the main drawbacks of LDCT lung cancer screening?",{"text":118,"@type":114},"LDCT has high false-positive rates that can cause overdiagnosis and unnecessary surgeries. It also adds risk and cost associated with repeated exposure to ionizing radiation.",{"name":120,"@type":111,"acceptedAnswer":121},"Why are exosomes considered promising for early lung cancer diagnostics?",{"text":122,"@type":114},"Exosomal RNAs and proteins can serve as biomarkers in body fluids because they are relatively stable and accessible. They may provide disease specificity while supporting noninvasive testing through liquid biopsy.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},350897,1790387420,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","TYPE Review  \nPUBLISHED 07 January 2026 DOI 10.3389/fcell.2025.1739242  \nOPEN ACCESS  \nEDITED BY  \nKai Li,  \nSichuan University, China  \nREVIEWED BY  \nNagendra Verma,  \nSt. Cloud State University, United States Peipei Wu,  \nUniversity of Science and Technology of China, China  \n*CORRESPONDENCE  \nQian Wang,  \n [liaoningpanda@163.com](liaoningpanda@163.com)  \n†These authors have contributed equally to this work  \nRECEIVED 04 November 2025  \nREVISED 14 December 2025  \nACCEPTED 16 December 2025  \nPUBLISHED 07 January 2026  \nCITATION  \nLiu X, Xu X and Wang Q (2026) Exosomes in early lung cancer diagnostics: the current state of progress made and prospects.  \nFront. Cell Dev. Biol. 13:1739242 .  \ndoi: 10.3389/fcell.2025.1739242  \nCOPYRIGHT  \n© 2026 Liu, Xu and Wang. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nExosomes in early lung cancer diagnostics: the current state of progress made and prospects  \nXiaotian Liu 1†, Xianlin Xu 2† and Qian Wang 1*  \n1Department of Anesthesiology, Children’s Hospital of Soochow University, Suzhou, China, 2Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China  \nThe high mortality rate of lung cancer primarily results from its late-stage diagnosis, at which point metastasis has usually occurred and therapeutic options are limited, leading to an overall 5-year survival rate below 20% inmost countries. The current screening method, low-dose computed tomography (LDCT), faces challenges such as high false-positive rates, which can result in overdiagnosis and unnecessary surgeries, as well as the risk of cancer due to repeated exposure to ionizing radiation. Although tumor tissue detection remains the gold standard for cancer diagnosis, it is limited by invasive sampling procedures that may cause patient trauma, as well as by tumor heterogeneity and inconsistent tissue quality, which can compromise diagnostic accuracy. Due to these challenges among others, researchers have been exploring better diagnostic methods that are not only sensitive and specific but also noninvasive, utilizing easily available samples with good reproducibility. In recent years, studies have revealed that humoral-derived materials, such as exosomal RNAs and proteins are considered the most promising biomarkers for the early diagnosis of lung cancer in body fluids owing to their stability, accessibility, and specificity. This study reviews current research on the exploration of exosomes as early diagnostic markers for lung cancer. Both established methods and emerging technologies, such as surface-enhanced Raman spectroscopy (SERS), lateral flow immunoassays (LFIA), microfluidics, and electric fieldinduced release and measurement (EFIRM), as well as commercial products, are discussed.  \nKEYWORDS  \nearly diagnosis, exosomal biomarker, exosome, liquid biopsy, lung cancer  \n1 Introduction  \nAccording to global cancer statistics, lung cancer ranks as the most frequently diagnosed cancer (accounting for 12.4% of all cases) and the foremost cause of cancer-related mortality (responsible for 18.7% of all cancer deaths) when considering both sexes combined (Brayet al., 2024) . Non-small cell lung cancer (NSCLC) represents the most prevalent form of lung cancer, encompassing two primary pathological subtypes: adenocarcinoma (AdCa) and squamous cell carcinoma (SCC) . The 5-year relative survival rate for lung cancer remains below 20% in the majority of countries, underscoring the critical importance of early detection in reducing the disease’s mortality rates (Fox et al., 2023). Current screening methodologies, includ","cbCaisM0KPyn0P70","https://ap.wps.com/l/cbCaisM0KPyn0P70","pdf",2896472,17,"English","# Introduction\n## Global burden and survival context\n## Screening methods and limitations\n## Need for noninvasive biomarkers","[{\"question\":\"Why is early lung cancer detection critical?\",\"answer\":\"Late-stage diagnosis is common, often after metastasis has occurred, and therapeutic options are limited, leading to low survival rates. Early detection can reduce mortality by catching disease earlier.\"},{\"question\":\"What are the main drawbacks of LDCT lung cancer screening?\",\"answer\":\"LDCT has high false-positive rates that can cause overdiagnosis and unnecessary surgeries. It also adds risk and cost associated with repeated exposure to ionizing radiation.\"},{\"question\":\"Why are exosomes considered promising for early lung cancer diagnostics?\",\"answer\":\"Exosomal RNAs and proteins can serve as biomarkers in body fluids because they are relatively stable and accessible. They may provide disease specificity while supporting noninvasive testing through liquid biopsy.\"}]","Exosomes in early lung cancer diagnostics: the current state of progress made and prospects | PDF",1790091713,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3526e49e220a6836c677dd6811b34794.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2fb214f93bc40ce99c0ca437de3db92a.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92d4e9c83148d3e9b037644c74b5aba2.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c14f2f6b2893fb6bac617dfa75fe33ef.webp",980,1385]